Company / Gross Margin
STAAR Surgical Company Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
76.2%
FY2025
5-year range
74.5% / 93.3%
FY2021-FY2025
Trend
-0.2%
vs FY2024
Sector context
#10 of 96
Health Care
What the data says
Among 96 Health Care companies, STAAR Surgical Company is in the top 10% for gross margin. Gross Margin has declined for 3 consecutive years, from 93.3% in FY2022 to 76.2% in FY2025.
Based on SEC 10-K filings.
76.2% in FY2025 with a 5-year CAGR of +2.4%. Top quartile in the Health Care sector.
Declined from 78.4% to 76.2% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -17.1pp
- 5-Year Change
- +2.4pp
- 10-Year Change
- -
Sector benchmark
Top 10% in Health CareTop 10% of 96This company 76.2% Sector average 53.6%
▼
+42.2% above sector average
Key checks
Key Insights
- STAAR Surgical Company's gross margin has declined for 3 consecutive years.
- In FY2025, gross margin decreased 0.2% year-over-year.
- Currently 22.6pp above the Health Care sector average.
- Peak gross margin was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Negative profit margin: -6.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 76.2% | -0.2% |
| FY2024 | 76.3% | -2.6% |
| FY2023 | 78.4% | -16.0% |
| FY2022 | 93.3% | +25.2% |
| FY2021 | 74.5% | +1.0% |
| FY2020 | 73.8% | -1.0% |
| FY2019 | 74.5% | +5.3% |
| FY2018 | 70.8% | -70.5% |
| FY2017 | 240.4% | +239.4% |
| FY2016 | 70.8% | -77.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026